Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
03 juil. 2024 08h00 HE
|
Olink Proteomics AB
Inaugural network of Olink® Certified Service Providers includes eading contract research organizations (CROs) and service labs around the world.
Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific Northwest
09 mai 2024 09h00 HE
|
Curia Global, Inc.
The symposium, Unlocking High-Throughput Biology in Drug Discovery, will take place on May 31 in Seattle and feature industry-leading scientists.
Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics
05 nov. 2023 20h00 HE
|
Olink Proteomics AB
Novogene AMEA to begin offering Olink Explore HT high-throughput proteomics services to unravel the connections between genes, proteins, and diseases.
Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomics
05 oct. 2023 16h25 HE
|
Olink Proteomics AB
Three landmark studies published in Nature demonstrate the power of Olink technology for understanding human biology.
Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
28 sept. 2023 08h00 HE
|
Quris Technologies
Merck KGaA and Quris-AI Expand Collaboration After a Successful Preclinical Study Assessed the Quris-AI BioAI Drug Safety Platform
Orion Biotechnology Completes Discovery of First-in-Class Molecule Against Undrugged GPCR Target in Four Months
18 juil. 2023 11h33 HE
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, July 18, 2023 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
Chemical Computing Group and Discngine Join Forces
22 déc. 2022 15h00 HE
|
Chemical Computing Group
MONTREAL, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Chemical Computing Group ULC ("CCG") announced today that it has acquired Discngine SAS ("Discngine"), a company that develops state-of-the-art IT...
Deepfake Technology in Drug Design
20 oct. 2022 12h00 HE
|
InSilico Medicine
New York, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage artificial intelligence (AI)-driven drug discovery company, is utilizing the same deepfake technology used to create...
Healthcare Triangle Facilitates Secure Data Sharing for Drug Discovery Through Neutral Zone
05 juil. 2022 08h00 HE
|
Healthcare Triangle, Inc.
PLEASANTON, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc., (Nasdaq: HCTI) (“HCTI” or the "Company") enables collaborative data sharing and analysis through “neutral zone”. A...
InveniAI Enters Strategic Artificial Intelligence Collaboration with Kyowa Hakko Kirin
11 déc. 2018 08h00 HE
|
InveniAI
BRANFORD, Conn., Dec. 11, 2018 (GLOBE NEWSWIRE) -- InveniAI® Corporation, a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform...